The Leela is entering a new phase of expansion post its IPO, but it is not straying away from its luxury proposition.

Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ('Ascentage Pharma” or the 'Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, ...

Interpublic Group cited three large account losses from 2024 that impacted the business, especially in media and healthcare.

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Results: JSW Infrastructure on Tuesday, July 22, posted a strong double-digit growth in its net profit and revenue for the ...

Shares of Pfizer Inc. PFE rallied 3.63% to $25.14 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and the ...

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

PennyMac Financial (PFSI) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.67 per share a year ago. These ...

Amgen saw its price target boosted from $315 to $326 by UBS Group, maintaining a neutral stance. This upgrade reflects a ...